Obstetrics and Gynecology
9 questionsWhat is meant by 'Battledore insertion of placenta'?
Which of the following is NOT a cause of metrorrhagia?
Bonney's test is used to determine which of the following?
Red degeneration of fibroid is seen in which of the following?
Which of the following statements about radical hysterectomy in stage Ib cervical cancer compared to radiotherapy is false?
A patient presents with bilateral ovarian carcinoma, capsule involvement, ascites, and paraaortic lymphadenopathy. What is the appropriate stage of the disease?
Most common presentation of cervical cancer is -
What is the first-line treatment for simple hyperplasia of the endometrium?
What is the most common presenting feature of a complete mole?
NEET-PG 2013 - Obstetrics and Gynecology NEET-PG Practice Questions and MCQs
Question 1181: What is meant by 'Battledore insertion of placenta'?
- A. Placenta attached to the margin of the membranes
- B. Placenta attached to the center of the uterus
- C. Umbilical cord attached to the margin of the placenta (Correct Answer)
- D. Umbilical cord attached to the membranes
Explanation: ***Umbilical cord attached to the margin of the placenta*** - In a **Battledore insertion**, the **umbilical cord** inserts into the **edge** or **margin** of the placenta, rather than its center. - This unusual insertion resembles a **battledore**, a type of ancient racket or paddle with a handle at its edge (similar to those used in shuttlecock games). *Placenta attached to the margin of the membranes* - This description is more consistent with a **circumvallate placenta**, where the chorionic plate is smaller than the basal plate, leading to a rolled or folded margin of placental tissue covered by membranes, but it does not describe Battledore insertion. - In circumvallate placenta, the chorionic plate's edge rolls back and is surrounded by a ring of membranes, while Battledore refers specifically to the cord's insertion. *Placenta attached to the center of the uterus* - This simply indicates a **normal location** for the placenta within the uterine cavity and does not describe any abnormal insertion of the umbilical cord or specific characteristics of the placenta itself. - The placenta typically attaches to the uterine wall and can be central, fundal, or anterior/posterior, but this statement doesn't relate to the cord's insertion point. *Umbilical cord attached to the membranes* - This condition is known as **velamentous insertion of the umbilical cord**, where the cord blood vessels fan out within the amniotic membrane before reaching the placental tissue. - Velamentous insertion is a distinct anomaly from Battledore insertion and carries different risks, such as vasa previa and a higher risk of vessel compression or rupture.
Question 1182: Which of the following is NOT a cause of metrorrhagia?
- A. Polyp
- B. CA endometrium
- C. IUD
- D. Intramural fibroid (Correct Answer)
Explanation: ***Intramural fibroid*** - **Intramural fibroids** are located within the uterine wall and are **primarily associated with menorrhagia** (heavy or prolonged menstrual bleeding during regular periods) rather than metrorrhagia. - Their main effect is to increase the endometrial surface area and impair uterine contractility, leading to **heavy regular menstrual flow**. - While they can occasionally cause irregular bleeding if complicated by degeneration or severe distortion, this is **not their typical presentation**, making them the **least characteristic cause** of metrorrhagia among the given options. *Polyp* - **Endometrial polyps** are **classic causes of metrorrhagia** because their friable surface bleeds irregularly, especially with hormonal fluctuations or minor trauma. - They commonly present with **intermenstrual spotting** and post-coital bleeding, making them a typical cause of irregular bleeding. *CA endometrium* - **Endometrial carcinoma** is a **frequent cause of metrorrhagia**, particularly in postmenopausal women, due to irregular shedding of friable malignant tissue. - The abnormal vascular supply and tissue breakdown in cancer results in **unpredictable, irregular bleeding episodes** characteristic of metrorrhagia. *IUD* - **Intrauterine devices** are **well-known causes of metrorrhagia**, particularly copper IUDs, which cause endometrial irritation and increased prostaglandin release. - Both copper and hormonal IUDs frequently cause **spotting and irregular intermenstrual bleeding**, especially in the first 3-6 months after insertion.
Question 1183: Bonney's test is used to determine which of the following?
- A. Urinary incontinence due to stress (Correct Answer)
- B. Uterine prolapse
- C. Vesicovaginal fistula
- D. Ureteric fistula
Explanation: ***Urinary incontinence due to stress*** - **Bonney's test** is specifically designed to assess whether a patient's **stress urinary incontinence** is correctable by elevating the urethrovesical junction. - A positive result, where urine leakage stops with elevation, suggests that surgical correction to support the urethra may be beneficial. *Uterine prolapse* - While related to pelvic floor dysfunction, **uterine prolapse** is assessed by clinical examination for descent of the uterus, not specifically with Bonney's test. - Its presence is determined by visible or palpable protrusion of the cervix or uterus through the vaginal opening. *Vesicovaginal fistula* - A **vesicovaginal fistula** involves an abnormal connection between the bladder and vagina, leading to continuous urine leakage. - This condition is typically diagnosed using dye tests (e.g., tampon test) or cystoscopy, not Bonney's test. *Ureteric fistula* - A **ureteric fistula** is an abnormal connection involving the ureter, often resulting in continuous urine leakage outside the normal urinary tract. - Diagnosis usually involves imaging studies like IV urography or CT urogram, as Bonney's test is not relevant for this condition.
Question 1184: Red degeneration of fibroid is seen in which of the following?
- A. Early pregnancy
- B. Mid pregnancy (Correct Answer)
- C. Nulliparous women
- D. Puerperium
Explanation: ***Mid pregnancy*** - **Red degeneration**, or **carneous degeneration**, is most common during the **second and third trimesters of pregnancy** due to increased metabolic demands of the growing fibroid outstripping its blood supply. - The rapid growth leads to **ischemia**, hemorrhage, and necrosis within the fibroid, causing acute abdominal pain. *Early pregnancy* - While fibroids can grow in early pregnancy, **red degeneration** is less common as the uterine blood supply is generally still adequate to meet the fibroid's metabolic needs. - Other forms of degeneration, like **hyaline degeneration**, are more frequently observed in non-pregnant or early pregnant states. *Puerperium* - In the puerperium, fibroids typically undergo **regression** rather than degeneration, as the hormonal stimulation (estrogen and progesterone) that promoted their growth significantly decreases. - The uterus involutes rapidly, and fibroids often shrink. *Nulliparous women* - Nulliparous women can have fibroids and experience various forms of degeneration, but **red degeneration** specifically is rare outside of pregnancy. - Degeneration in nulliparous women is more commonly **hyaline** or **cystic** degeneration.
Question 1185: Which of the following statements about radical hysterectomy in stage Ib cervical cancer compared to radiotherapy is false?
- A. Chance of recurrence is lower with radical hysterectomy.
- B. Ovarian function can be preserved.
- C. Chance of survival is higher with radical hysterectomy.
- D. It is less complicated than radiotherapy. (Correct Answer)
Explanation: ***It is less complicated than radiotherapy.*** - Radical hysterectomy is a **major surgical procedure** with potential complications like **hemorrhage**, infection, **ureteral injury**, and **lymphedema**, which can be significant and life-altering. - Radiotherapy, while having its own set of side effects (e.g., **vaginal stenosis**, bladder/rectal irritation), typically avoids the acute surgical risks and recovery period associated with extensive surgery. *Chance of recurrence is lower with radical hysterectomy.* - For early-stage cervical cancer (Ib1/Ib2), both **radical hysterectomy** and **radiotherapy** provide **comparable outcomes** in terms of recurrence rates. - The choice between therapies often depends on patient factors, surgeon expertise, and pathological findings, but neither consistently demonstrates a significantly lower recurrence rate over the other in large cohorts. *Ovarian function can be preserved.* - In younger patients undergoing **radical hysterectomy**, it is often possible to **preserve the ovaries** by transplanting them or avoiding their removal if not directly involved, thus maintaining **endocrine function**. - **Pelvic radiotherapy**, in contrast, invariably leads to **ovarian radiation** and subsequent **ovarian failure** and menopause. *Chance of survival is higher with radical hysterectomy.* - For early-stage cervical cancer (Ib), **overall survival rates** are generally **equivalent** between radical hysterectomy and primary radiotherapy. - Meta-analyses and large retrospective studies have shown **similar 5-year survival rates** for both treatment modalities when applied appropriately to well-selected patients.
Question 1186: A patient presents with bilateral ovarian carcinoma, capsule involvement, ascites, and paraaortic lymphadenopathy. What is the appropriate stage of the disease?
- A. Stage 1C
- B. Stage 3C (Correct Answer)
- C. Stage 2C
- D. Stage 4C
Explanation: ***Stage 3C*** - **Bilateral ovarian carcinoma** with **capsule involvement**, **ascites**, and especially **paraaortic lymph node metastases** are defining features of Stage IIIC ovarian cancer. - Involvement of **retroperitoneal lymph nodes**, including paraaortic nodes, automatically upstages the disease to Stage III, irrespective of other abdominal spread. *Stage 1C* - This stage refers to ovarian cancer confined to **one or both ovaries**, with evidence of rupture, capsule involvement, or malignant cells in ascites/peritoneal washings, but **without lymph node involvement**. - The presence of **paraaortic lymphadenopathy** in this patient immediately excludes Stage 1C. *Stage 2C* - Stage 2 ovarian cancer involves one or both ovaries with **pelvic extension** beyond the ovaries, but still **without lymph node involvement**. - The patient's involvement of **paraaortic lymph nodes** goes beyond pelvic extension and therefore excludes Stage 2C. *Stage 4C* - Stage 4 ovarian carcinoma involves **distant metastasis** beyond the peritoneal cavity or distant lymph nodes (e.g., pleural effusion with positive cytology, parenchymal liver/spleen metastasis). - While paraaortic lymphadenopathy indicates advanced disease, it falls within the criteria for Stage 3 due to its location, not Stage 4.
Question 1187: Most common presentation of cervical cancer is -
- A. Abnormal vaginal bleeding (Correct Answer)
- B. Pelvic pain
- C. Pain during intercourse
- D. Unusual vaginal discharge
Explanation: ***Abnormal vaginal bleeding*** - **Abnormal vaginal bleeding** is the most frequent presenting symptom of cervical cancer, often manifesting as **postcoital bleeding**, intermenstrual bleeding, or heavier, longer menstrual periods. - This symptom arises as the tumor on the cervix ulcerates and bleeds due to its friable nature and rich vascularization. *Pelvic pain* - **Pelvic pain** is typically a symptom of more **advanced cervical cancer**, indicating tumor invasion into surrounding tissues or nerves. - It is not usually an early or the most common presenting symptom, unlike abnormal bleeding. *Pain during intercourse* - **Pain during intercourse (dyspareunia)** can be a symptom of cervical cancer, particularly with larger lesions or those causing inflammation. - However, it is less common than abnormal bleeding and often occurs concurrently with or after the onset of bleeding symptoms. *Unusual vaginal discharge* - An **unusual vaginal discharge**, which may be watery, foul-smelling, or blood-tinged, can occur with cervical cancer. - While a common symptom, it is generally considered less frequent than abnormal vaginal bleeding as the primary presenting complaint.
Question 1188: What is the first-line treatment for simple hyperplasia of the endometrium?
- A. Endometrial ablation (surgical procedure)
- B. Estrogen therapy (e.g., Estradiol)
- C. Total abdominal hysterectomy (surgical removal of the uterus)
- D. Progestin therapy (e.g., Medroxyprogesterone acetate) (Correct Answer)
Explanation: ***Progestin therapy (e.g., Medroxyprogesterone acetate)*** - **Progestin therapy** is the first-line treatment for simple endometrial hyperplasia because it counteracts the unopposed estrogen effect causing the hyperplasia. - **Progestins** lead to endometrial atrophy and shedding, helping to reverse the hyperplastic changes and prevent progression to cancer. *Estrogen therapy (e.g., Estradiol)* - **Estrogen therapy** without concomitant progestins would exacerbate endometrial hyperplasia by further stimulating endometrial growth. - This treatment is contraindicated in cases of endometrial hyperplasia unless carefully balanced with progestins. *Endometrial ablation (surgical procedure)* - **Endometrial ablation** is a destructive procedure to remove the endometrial lining and is typically considered for persistent abnormal uterine bleeding, not as a primary treatment for simple hyperplasia. - It is often reserved for patients who have completed childbearing and fail medical management. *Total abdominal hysterectomy (surgical removal of the uterus)* - A **total abdominal hysterectomy** is an invasive surgical procedure that is generally reserved for complex or atypical endometrial hyperplasia, or hyperplasia that is recurrent and unresponsive to medical management. - It is not the first-line treatment for simple hyperplasia, especially in patients who may desire future fertility or wish to avoid major surgery.
Question 1189: What is the most common presenting feature of a complete mole?
- A. Vomiting
- B. Hyperemesis gravidarum
- C. Amenorrhoea
- D. Bleeding per vaginum (Correct Answer)
Explanation: ***Bleeding per vaginum (Correct)*** - **Vaginal bleeding** in the first or early second trimester is the **most common presenting symptom** of a complete hydatidiform mole, occurring in approximately 80-90% of cases - This bleeding can vary in amount and color, often described as **prune juice-like** discharge with passage of grape-like vesicles in some cases - Typically presents between **6-16 weeks of gestation** as the most frequent initial clinical sign *Vomiting (Incorrect)* - While nausea and vomiting are common in normal pregnancies, this is **not the most common presenting feature** of a complete mole - Vomiting may occur but is less specific and typically occurs after or in conjunction with vaginal bleeding - When severe, it manifests as hyperemesis gravidarum (a separate entity) *Hyperemesis gravidarum (Incorrect)* - This condition, characterized by **severe, persistent nausea and vomiting**, is more prevalent in molar pregnancies due to **excessively high hCG levels** - Occurs in approximately **25-30% of complete moles**, making it a significant but not the most common presentation - It is a **consequence** of the molar pregnancy, often presenting **after** initial bleeding, and is not the most frequent first clinical sign *Amenorrhoea (Incorrect)* - **Amenorrhoea** (absence of menstruation) is a **universal symptom** of any pregnancy, including a molar pregnancy - While it indicates conception, it does **not differentiate** a molar pregnancy from a normal pregnancy or other causes of amenorrhoea - Therefore, it is not the most specific or common **presenting feature** that would lead to diagnosis of a molar pregnancy
Radiology
1 questionsWhat is the standard radiation dose to point A in the cervix for brachytherapy in the treatment of cervical cancer?
NEET-PG 2013 - Radiology NEET-PG Practice Questions and MCQs
Question 1181: What is the standard radiation dose to point A in the cervix for brachytherapy in the treatment of cervical cancer?
- A. 8000 rad (Correct Answer)
- B. 6000 rad
- C. 10000 rad
- D. 4000 rad
Explanation: ***8000 rad*** - The standard **total cumulative radiation dose** to **Point A** in the cervix for the treatment of cervical cancer is approximately **8000 rad (80 Gy)**. - This represents the **combined dose** from external beam radiation therapy (EBRT, typically 45-50 Gy) plus intracavitary brachytherapy (typically 30-40 Gy to Point A). - Point A is a classical reference point defined as **2 cm superior to the external cervical os and 2 cm lateral to the uterine canal**, representing the location where the uterine artery crosses the ureter. - This total dose aims to provide adequate tumor control while minimizing toxicity to surrounding organs like the bladder and rectum. *6000 rad* - A total dose of **6000 rad** is insufficient for definitive local control of cervical cancer. - This dose is below the therapeutic threshold and would result in significantly higher rates of local recurrence and treatment failure. - Adequate doses are essential for curative intent in cervical cancer management. *10000 rad* - A dose of **10000 rad** to Point A would be excessively high and significantly increase the risk of severe acute and late toxicities to surrounding tissues. - Such a high dose could lead to serious complications including **rectovaginal or vesicovaginal fistulas, proctitis, cystitis, bowel strictures, and tissue necrosis**. - The therapeutic window would be exceeded, causing more harm than benefit. *4000 rad* - A dose of **4000 rad** would be substantially lower than the standard therapeutic dose for cervical cancer. - This suboptimal dose would likely result in **inadequate tumor control and increased risk of local recurrence**. - It is far below the dose required for curative treatment of cervical cancer.